# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-10T20:20:47.688485
**Route:** OpenRouter + LaTeX
**Tokens:** 15070 in / 1940 out
**Response SHA256:** b7c93444778ef0f0

---

I reviewed the manuscript for the narrow set of FATAL errors you asked me to flag (data-design alignment, regression sanity, completeness, and internal consistency). I focused only on items that would embarrass the author or make the submission unusable for referees.

Summary judgment: I did NOT find any fatal errors in the categories you specified.

Notes supporting PASS (no fatal errors found)

- Data-design alignment
  - Treatment timing vs. data coverage: The QCEW sample is stated as 2015Q1–2025Q2 and treatment effective dates are assigned to quarters consistently (e.g., California 2020Q1, Virginia 2023Q1, etc.). The paper states that thirteen states have at least one post-treatment quarter in the QCEW data; this is internally consistent with treatment dates reported (several states effective in 2025Q1 would have one post-treatment quarter by 2025Q2). The BFS data are explicitly restricted to 2015Q1–2020Q4 and the author correctly notes that only California is treated in that window—this is flagged and interpreted appropriately in the text. I therefore find no impossible timing claims (no claim that the estimator uses post-2025 data when the data stop in 2025Q2).
  - Post-treatment observations: The manuscript explicitly acknowledges which states have zero post-treatment quarters and how the CS estimator handles those cases. Event-study windows and the ATT aggregation are described with those constraints in mind.
  - Treatment definition consistency: The treatment coding convention is described consistently across the main text and appendix (first full quarter treated, first_treat variable conventions following the did package). Examples (California = 2020Q1, Virginia = 2023Q1, Oregon/Utah coding) are consistent.

- Regression sanity
  - Reported coefficients and standard errors shown in the body appear plausible (e.g., ATT = -0.0767, SE = 0.0247 for Software Publishers). No reported SEs that are implausibly large (>>1,000) or negative, no coefficients that exceed the flagged impossible thresholds, and no R² reported outside [0,1] in the text. The randomization inference p-value and bootstrap replications are reported and interpreted consistently.
  - Placebo results and robustness checks are described and their reported magnitudes/SEs are within reasonable ranges. I saw no signs of NaN/Inf/NA values in displayed numeric results in the main text.

- Completeness
  - I found no explicit placeholder tokens such as "TBD", "TODO", "XXX", or "PLACEHOLDER" in the manuscript text.
  - The author explicitly states data sample size (panel dimension 2,226 state-quarter observations) and documents the BFS sample span and its limitations. The estimation and inference procedures (clustered SEs, bootstrap replications, number of permutations) are described in detail.
  - The paper acknowledges limitations (short post-treatment windows for many states, BFS identification limited to California) rather than leaving analyses promised but not shown.

- Internal consistency
  - Narrative claims (e.g., which states are in which cohorts, which outcomes are used for which figures/tables) match the technical descriptions in the data and appendix sections.
  - The paper consistently distinguishes between NAICS 5112 (Software Publishers) and broader NAICS 51 outcomes and explains why some analyses (BFS) are identified only by California in the pre-2021 window.
  - Event-study windows, the use of never-treated controls for the CS estimator, and robustness checks (TWFE, Sun-Abraham IW) are described consistently throughout.

A few non-fatal issues and suggestions (not required for the PASS/FAIL decision)
- I could not inspect the contents of the \input{tables/...} files and figure files from the LaTeX source you provided; these are conventionally stored externally. Ensure that when you submit to the journal you include all external table/figure files and verify that the compiled PDF displays every table and figure correctly. (This is not a fatal error in the manuscript content itself but a practical compilation check.)
- Confirm that regression tables include sample sizes (N) and number of clusters used for clustering SEs. The text reports the panel dimension, but regression tables should explicitly report N and number of clustered units to satisfy referees (you likely have these in the external tables; if not, add them).
- Confirm that the robustness tables include standard errors/confidence intervals for every reported coefficient (again, this is standard practice; the text states SEs are reported).

Final verdict:
ADVISOR VERDICT: PASS